Palo Alto, CALIFORNIA3 Active Studies

Prader-Willi Syndrome Clinical Trials in Palo Alto, CALIFORNIA

Find 3 actively recruiting prader-willi syndrome clinical trials in Palo Alto, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
282
Enrolling

Recruiting Prader-Willi Syndrome Studies in Palo Alto

About Prader-Willi Syndrome Clinical Trials in Palo Alto

Prader-Willi syndrome is a rare genetic disorder caused by loss of gene function on chromosome 15, leading to constant hunger, obesity, intellectual disability, and short stature. It is the most common genetic cause of life-threatening obesity. Management includes growth hormone therapy and strict dietary supervision.

There are currently 3 prader-willi syndrome clinical trials recruiting participants in Palo Alto, CALIFORNIA. These studies are seeking a combined 282 participants. Research is being sponsored by Foundation for Prader-Willi Research, Aardvark Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prader-Willi Syndrome Clinical Trials in Palo Alto — FAQ

Are there prader-willi syndrome clinical trials in Palo Alto?

Yes, there are 3 prader-willi syndrome clinical trials currently recruiting in Palo Alto, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Palo Alto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.

Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.

What prader-willi syndrome treatments are being tested?

The 3 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for prader-willi syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov